An object of the present invention is to provide a cell population comprising mesenchymal stem cells having high angiogenic capacity, a method for producing the same, a mesenchymal stem cell having high angiogenic capacity, and a pharmaceutical composition comprising the cell population. Also provided are methods for producing a cell population comprising mesenchymal stem cells, in particular methods comprising obtaining a cell population having the following cell characteristics (a) and (b): (a) the proportion of CDH6-positive mesenchymal stem cells is 30% or more in the cell population； and (b) the relative expression level of ADAM19 gene to the expression level of SDHA gene is 3.0 or more in the cell population.
